Qube Research & Technologies (QRT)
SWAV

Qube Research & Technologies (QRT)’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,036
Closed -$1.31M – 4934
2024
Q1 		$1.31M Buy
4,036
+3,874
+2,391% +$951K ﹤0.01% 1982
2023
Q4 		$30.9K Sell
162
-12,277
-99% -$2.32M ﹤0.01% 3413
2023
Q3 		$2.48M Sell
12,439
-80,857
-87% -$19.1M 0.01% 1268
2023
Q2 		$26.6M Buy
+93,296
New +$25.9M 0.1% 277
2023
Q1 		– Sell
-64,053
Closed -$13.2M – 3142
2022
Q4 		$13.2M Buy
64,053
+27,374
+75% +$6.92M 0.07% 399
2022
Q3 		$10.2M Buy
+36,679
New +$9.33M 0.06% 409
2021
Q3 		– Sell
-17,945
Closed -$3.4M – 2910
2021
Q2 		$3.4M Buy
+17,945
New +$2.94M 0.04% 531
2021
Q1 		– Sell
-2,791
Closed -$289K – 2519
2020
Q4 		$289K Buy
+2,791
New +$242K ﹤0.01% 1374

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SWAV Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 4,036 shares — an estimated $1.31M sold.

Qube Research & Technologies (QRT) first reported a position in SWAV in Q4 2020 and held it in 8 quarters. The position peaked at $26.6M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 4,036 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.31M.
  • Qube Research & Technologies (QRT) first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Shockwave Medical, Inc. Common Stock position peaked at $26.6M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.